Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

1.

Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study.

Lancet.
Tawakol A, Ishai A, Takx RA, Figueroa AL, Ali A, Kaiser Y, Truong QA, Solomon CJ, Calcagno C, Mani V, Tang CY, Mulder WJ, Murrough JW, Hoffmann U, Nahrendorf M, Shin LM, Fayad ZA, Pitman RK.
| Jan 12, 2017
2.

Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study.

Lancet.
Lortholary O, Chandesris MO, Livideanu CB, Paul C, Guillet G, Jassem E, Niedoszytko M, Barete S, Verstovsek S, Grattan C, Damaj G, Canioni D, Fraitag S, Lhermitte L, Lavialle SG, Frenzel L, Afrin LB, Hanssens K, Agopian J, Gaillard R, Kinet JP, Auclair C, Mansfield C, Moussy A, Dubreuil P, Hermine O.
| Feb 11, 2017
3.

Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.

Lancet.
El-Khatib FH, Balliro C, Hillard MA, Magyar KL, Ekhlaspour L, Sinha M, Mondesir D, Esmaeili A, Hartigan C, Thompson MJ, Malkani S, Lock JP, Harlan DM, Clinton P, Frank E, Wilson DM, DeSalvo D, Norlander L, Ly T, Buckingham BA, Diner J, Dezube M, Young LA, Goley A, Kirkman MS, Buse JB, Zheng H, Selagamsetty RR, Damiano ER, Russell SJ.
| Jan 28, 2017
4.

Filgotinib for Crohn's disease-expanding treatment options.

Lancet.
Ananthakrishnan AN.
| Jan 21, 2017
5.

Shelf life considerations as EpiPen price increases.

Lancet.
Bartenstein DW, Diven DG.
| Dec 10, 2016
6.

Patient-physician trust in China: a workshop summary.

Lancet.
Chan CS, Cheng Y, Cong Y, Du Z, Hu S, Kerrigan A, Kleinman A, Li M, Liebman B, Ma Y, Nie JB, Tsai DF, Tsai D, Tucker JD, Wang L, Wong B, Wong WC, Xiao Z, Xu J, Yan Y, Yang Y, Zhang D, Zhao M, Zhu J, Zhu W.
| 12 15, 2016
7.

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.

Lancet.
Balar AV, Galsky MD, Rosenberg JE, Powles T, Petrylak DP, Bellmunt J, Loriot Y, Necchi A, Hoffman-Censits J, Perez-Gracia JL, Dawson NA, van der Heijden MS, Dreicer R, Srinivas S, Retz MM, Joseph RW, Drakaki A, Vaishampayan UN, Sridhar SS, Quinn DI, Durán I, Shaffer DR, Eigl BJ, Grivas PD, Yu EY, Li S, Kadel EE, Boyd Z, Bourgon R, Hegde PS, Mariathasan S, Thåström A, Abidoye OO, Fine GD, Bajorin DF.
| 01 07, 2017
8.

Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial.

Lancet.
Teerlink JR, Felker GM, McMurray JJ, Solomon SD, Adams KF, Cleland JG, Ezekowitz JA, Goudev A, Macdonald P, Metra M, Mitrovic V, Ponikowski P, Serpytis P, Spinar J, Tomcsányi J, Vandekerckhove HJ, Voors AA, Monsalvo ML, Johnston J, Malik FI, Honarpour N.
| Dec 10, 2016
10.

The post-Ebola baby boom: time to strengthen health systems.

Lancet.
McBain RK, Wickett E, Mugunga JC, Beste J, Konwloh P, Mukherjee J.
| Nov 12, 2016
11.

Essential medicines for universal health coverage.

Lancet.
Wirtz VJ, Hogerzeil HV, Gray AL, Bigdeli M, de Joncheere CP, Ewen MA, Gyansa-Lutterodt M, Jing S, Luiza VL, Mbindyo RM, Möller H, Moucheraud C, Pécoul B, Rägo L, Rashidian A, Ross-Degnan D, Stephens PN, Teerawattananon Y, 't Hoen EF, Wagner AK, Yadav P, Reich MR.
| Jan 28, 2017
12.

The ABC risk score for patients with atrial fibrillation.

Lancet.
Charidimou A.
| Oct 22, 2016
13.

The map is not the territory: medical records and 21st century practice.

Lancet.
Martin SA, Sinsky CA.
| Oct 22, 2016
14.

Early childhood development coming of age: science through the life course.

Lancet.
Black MM, Walker SP, Fernald LC, Andersen CT, DiGirolamo AM, Lu C, McCoy DC, Fink G, Shawar YR, Shiffman J, Devercelli AE, Wodon QT, Vargas-Barón E, Grantham-McGregor S.
| 01 07, 2017
15.

Investing in the foundation of sustainable development: pathways to scale up for early childhood development.

Lancet.
Richter LM, Daelmans B, Lombardi J, Heymann J, Boo FL, Behrman JR, Lu C, Lucas JE, Perez-Escamilla R, Dua T, Bhutta ZA, Stenberg K, Gertler P, Darmstadt GL.
| 01 07, 2017
16.

Expanding the evidence base to drive more productive early childhood investment.

Lancet.
Shonkoff JP, Radner JM, Foote N.
| 01 07, 2017
17.

The metabolic stress response to burn trauma: current understanding and therapies.

Lancet.
Porter C, Tompkins RG, Finnerty CC, Sidossis LS, Suman OE, Herndon DN.
| Oct 01, 2016
18.

Early, goal-directed mobilisation in the surgical intensive care unit: a randomised controlled trial.

Lancet.
Schaller SJ, Anstey M, Blobner M, Edrich T, Grabitz SD, Gradwohl-Matis I, Heim M, Houle T, Kurth T, Latronico N, Lee J, Meyer MJ, Peponis T, Talmor D, Velmahos GC, Waak K, Walz JM, Zafonte R, Eikermann M.
| Oct 01, 2016
19.

How the paediatric workforce can address the opioid crisis.

Lancet.
Hadland SE, Wood E, Levy S.
| Sep 24, 2016